News | Radiomics

Using data from computed tomography (CT) images, researchers may be able to predict which lung cancer patients will respond to chemotherapy, according to a new study published in the journal Radiology: Artificial Intelligence.

Time March 21, 2019
Home
News | Ultrasound Women's Health

QTbreasthealth has opened a new center in San Jose, Calif. The new location is now open and booking appointments for radiation-free breast imaging.

Time March 20, 2019
Home
News | Magnetic Resonance Imaging (MRI)

Fonar Corp. reported publication of a chapter where the physician-author-researchers utilized the Fonar Upright Multi-Position MRI (magnetic resonance imaging) system. The title of their chapter is: Craniocervical Junction Syndrome: Anatomy of the Craniocervical and Atlantoaxial Junctions and the Effect of Misalignment on Cerebrospinal Fluid Flow.

Time March 20, 2019
Home
Technology | Digital Radiography (DR)

The U.S. Food and Drug Administration (FDA) has cleared the Mobilett Elara Max mobile X-ray system from Siemens Healthineers. The system offers features that enable comprehensive information technology (IT) security as well as secure system integration into the hospital’s IT environment for anytime access to patient data. The system also has an improved design that includes an antimicrobial coating.

Time March 20, 2019
Home
News | Treatment Planning

Zuid-Oost Nederland Protonen Therapie Centrum (ZON-PTC), Maastricht, Netherlands, recently treated its first patient using the combination of the treatment planning system (TPS) RayStation from RaySearch in combination with the Mevion S250i Proton Therapy System with Hyperscan Pencil Beam Scanning.

Time March 19, 2019
Home
News | Focused Ultrasound Therapy

EDAP TMS SA announced that Houston Methodist Hospital, one of the first hospitals in the U.S. to offer Ablatherm robotic high intensity focused ultrasound (HIFU) for patients with localized prostate cancer, has acquired the advanced Focal One HIFU technology. Houston Methodist Hospital initially invested in EDAP's first-generation HIFU system, Ablatherm, in early 2016, and within two years of positive experience made the decision to invest in the next-generation Focal One device.

Time March 19, 2019
Home
News | Women's Health

Biologic age, a DNA-based estimate of a person’s age, is associated with future development of breast cancer, according to scientists at the National Institutes of Health. Biologic age was determined by measuring DNA methylation, a chemical modification to DNA that is part of the normal aging process. The study showed for every five years a woman’s biologic age was older than her chronologic or actual age, known as age acceleration, she had a 15 percent increase in her chance of developing breast cancer. The study was published online Feb. 22 in the Journal of the National Cancer Institute.

Time March 19, 2019
Home
News | Stroke

iSchemaView announced the company’s co-founder Gregory Albers, M.D., has received the Distinguished Clinical Research Achievement Award, presented by the Clinical Research Forum. The Distinguished Clinical Research Achievement Awards are presented to the top two studies that show creativity, innovation, or a novel approach that demonstrates an immediate impact on the health and well-being of patients.

Time March 19, 2019
Home
News | CT Angiography (CTA)

Late-breaking results confirm the HeartFlow FFRct (fractional flow reserve computed tomography) Analysis enables efficient identification of which patients, despite symptoms suggestive of coronary artery disease (CAD), have a low risk of adverse cardiovascular events and can safely avoid invasive testing out to one year. These results from the ADVANCE trial were presented as a late-breaking trial during the American College of Cardiology’s (ACC) 68th Annual Scientific Session, March 16-18 in New Orleans, and simultaneously published in the Journal of the American College of Cardiology (JACC): Cardiovascular Imaging.

Time March 19, 2019
Home
News | Advanced Visualization

DrChrono Inc. and 3D4Medical have teamed up so practices across the United States can access 3-D interactive modeling and animation videos from within their electronic health record (EHR) to better educate patients.

Time March 18, 2019
Home
News | PET Imaging

A new study positron emission tomography (PET) scans has identified a biomarker that may accurately predict which patients with one type of HER2-positive breast cancer might best benefit from standalone HER2-targeted agents, without the need for standard chemotherapy. The study was conducted by researchers at the Johns Hopkins Kimmel Cancer Center in an effort to further individualize therapy and avoid over-treating patients.

Time March 18, 2019
Home
Feature | Cardiac Imaging | By Greg Freiherr

As many as one in four patients who undergo cath lab interventions can benefit from a technology that identifies the ...

Time March 18, 2019
Home
News | Neuro Imaging

Brain magnetic resonance imaging (MRI) without contrast agent is just as effective as the contrast-enhanced approach for monitoring disease progression in patients with multiple sclerosis (MS), according to a new study in the journal Radiology. The findings support the possibility that contrast enhancement can be omitted from routine follow-up scans.

Time March 18, 2019
Home
Feature | Cardiac Imaging | By Greg Freiherr

Virtual reality (VR) and its less immersive kin, augmented reality (AR), are gaining traction in some medical ...

Time March 17, 2019
Home
Feature | Cardiac Imaging | By Greg Freiherr

Machine learning is already having an enormous impact on cardiology, automatically calculating measurements in ...

Time March 16, 2019
Home
News | Magnetic Resonance Imaging (MRI)

Calcium is a critical signaling molecule for most cells, and it is especially important in neurons. Imaging calcium in brain cells can reveal how neurons communicate with each other; however, current imaging techniques can only penetrate a few millimeters into the brain.

Time March 15, 2019
Home
Technology | Mammography

Fujifilm Medical Systems USA announced it has fulfilled all U.S. Food and Drug Administration (FDA) regulatory requirements for three new image processing and software advancements for its digital mammography system, Aspire Cristalle. Specifically, S-View, Iterative Super-resolution Reconstruction (ISR) and Tomosynthesis Spot — innovative tools designed to meet the dual challenge of higher image quality and lower dose — are now commercially available in the United States.

Time March 15, 2019
Home
Sponsored Content | Videos | Enterprise Imaging

As a VNA, GE Healthcare Centricity Clinical Archive weaves together data from many different sources and systems. The ...

Time March 15, 2019
Home
News | Cardiovascular Ultrasound

Artificial intelligence (AI) company Bay Labs announced the presentation of two studies assessing performance of the company’s deep learning software for cardiovascular imaging. The first evaluated the software when used by medical professionals with no prior ultrasound experience to acquire diagnostic-quality echocardiograms, and the second evaluated the fully automated calculation of ejection fraction (EF) with accuracy and increased reproducibility. Results from these studies will be presented at the American College of Cardiology (ACC) 68th Annual Scientific Session, March 16-18 in New Orleans.

Time March 15, 2019
Home
Podcast | Cardiac Imaging

Debate About Coronary Testing Highlights ACC Session

Time March 15, 2019
Home
Subscribe Now